Finance

Lists
Why is TORNTPHARM down 2,17%?
Dive Deeper
TORNTPHARM:NSE
Torrent Pharmaceuticals Ltd
4 614,00 ₹
-2,17%
(-102,20) 1D
8 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for TORNTPHARM...
Open
4 713,00 ₹
High
4 738,00 ₹
Low
4 592,30 ₹
Mkt. cap
1,58 տրլն
Avg. vol.
338,48 հզր
Volume
253,76 հզր
Dividend
0,82%
Quarterly dividend
9,50 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
73,71
52-wk high
5 250,00 ₹
52-wk low
3 480,60 ₹
EPS
62,60 ₹
Shares outstanding
170,00 մլն
No. of employees
18 հզր
Open
4 713,00 ₹
High
4 738,00 ₹
Low
4 592,30 ₹
Mkt. cap
1,58 տրլն
Avg. vol.
338,48 հզր
Volume
253,76 հզր
Dividend
0,82%
Quarterly dividend
9,50 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
73,71
52-wk high
5 250,00 ₹
52-wk low
3 480,60 ₹
EPS
62,60 ₹
Shares outstanding
170,00 մլն
No. of employees
18 հզր
News stories
From web sources and news partners
Profile
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
About Torrent Pharmaceuticals Ltd
CEO-
Employees18,3 հզր
Founded1959
HeadquartersԱհմեդաբադ, Գուջարաթ, Հնդկաստան
Sector-
Websitetorrentpharma.com
Last report
30 հլս, 2026 թ.
Fiscal period
Q1 2027
EPS / Est. (INR)
15,30 ₹ / 16,20 ₹
-5,55%miss
Revenue / Est. (INR)
49,21 մլրդ / 47,29 մլրդ
+4,07%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
33,02 մլրդ
33,03 մլրդ
41,97 մլրդ
49,21 մլրդ
Cost of goods sold
8,00 մլրդ
7,99 մլրդ
10,15 մլրդ
11,63 մլրդ
Cost of revenue
8,00 մլրդ
7,99 մլրդ
10,15 մլրդ
11,63 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,27 մլրդ
6,51 մլրդ
8,48 մլրդ
8,93 մլրդ
Operating expense
16,23 մլրդ
16,22 մլրդ
23,34 մլրդ
26,87 մլրդ
Total operating expenses
24,23 մլրդ
24,21 մլրդ
33,49 մլրդ
38,50 մլրդ
Operating income
8,79 մլրդ
8,82 մլրդ
8,48 մլրդ
10,71 մլրդ
Other non operating income
-270,00 մլն
-130,00 մլն
794,40 մլն
-120,00 մլն
EBT including unusual items
7,91 մլրդ
8,14 մլրդ
5,29 մլրդ
7,33 մլրդ
EBT excluding unusual items
8,04 մլրդ
8,24 մլրդ
5,47 մլրդ
7,54 մլրդ
Income tax expense
2,00 մլրդ
1,79 մլրդ
1,65 մլրդ
1,67 մլրդ
Effective tax rate
25,28%
21,99%
31,18%
22,78%
Other operating expenses
7,92 մլրդ
7,65 մլրդ
9,78 մլրդ
12,01 մլրդ
Net income
5,91 մլրդ
6,35 մլրդ
3,89 մլրդ
5,66 մլրդ
Net profit margin
17,90%
19,22%
9,28%
11,50%
Earnings per share
17,75
19,00
12,85
15,30
Interest and investment income
-
-
384,30 մլն
-
Interest expense
-480,00 մլն
-450,00 մլն
-2,36 մլրդ
-3,05 մլրդ
Net interest expenses
-480,00 մլն
-450,00 մլն
-1,97 մլրդ
-3,05 մլրդ
Depreciation and amortization charges
2,04 մլրդ
2,06 մլրդ
5,08 մլրդ
5,93 մլրդ
EBITDA
10,82 մլրդ
10,69 մլրդ
11,12 մլրդ
13,35 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps